Wednesday, January 19, 2022

Lexaria Bioscience Corp. (LEXX) Stock Performing Steadily and Consistently

Lexaria Bioscience Corp. (LEXX), a company operating in the drug delivery platform business, has steadily increased by 2.17% in aftermarket trading session. As a consequence, LEXX stock was trading at $6.58 when last checked. On Tuesday, LEXX stock closed the day at $6.44 after gaining a 2.22% increase in the regular trading session. The increase could be associated with excellent results of oral nicotine study.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


LEXX reported results from the nicotine absorption study

On Tuesday, LEXX reported that its recent oral nicotine absorption study, namely NIC-A21-1, has revealed that DehydraTECHTM-nicotine, which is delivered via the oral pouch product format, requires merely 2-4 minutes to deliver the nicotine levels in the blood plasma as compared to the levels achieved at 45 minutes with concentration-matched control. The DehydraTECH-nicotine also showed statistically significant peak blood plasma levels, up to 10 times higher than the control while still clearing from the blood virtually as quickly as the controls. The company said that it believes the findings would support the world’s fastest-acting nicotine oral mucosal absorption, which ultimately would offer the safer nicotine alternative to the more than 1 billion smokers worldwide. The study was conducted by a leading independent testing laboratory in the United States. It utilized Lexaria’s recently developed, advanced “DehydraTECH 2.0” nicotine formulations.

LEXX Q2 2021 financial results


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


On 15th July, LEXX reported the quarterly results for the third quarter of the fiscal year 2021, which ended 31st May 2021. According to the details, the company had cash and cash assets of $8.10 million on 31st May. The total assets in possession of the company remained at $10.54 million, while total liabilities stood at $0.28 million. The company generated revenue of $0.204 million, while during the comparative quarter of 2020, it stood at $36,423. The gross profit for the three months remained at $0.14 million, while for an equivalent period of 2020; the gross profit remained at $16,104. The net loss for continuing operations remained at $2.56 million, while during the equivalent period of 2020, it was $1.41 million. The net loss bore by the company shareholders for three month period remained at $2.55 million, while for an equivalent period of 2020, it was $1.36 million. The basic and diluted loss per share attributable to common shareholders remained at $0.50, while it was the same, i.e. $0.50, for a comparative three months period of 2020.  

What lies next for LEXX?

Looking at the stats, LEXXX stock hasn’t shown much fluctuation in recent past times. This shows the stability associated with the stock. Analysts are hopeful that the positive outcomes of the studies, especially the recent one related to nicotine absorption, would leave a marked impact on the business profile of Lexaria.

Latest news

Looking Under The Hood: What’s Happening To Bee Vectoring Technologies (BEVVF) Stock

Bee Vectoring Technologies International Inc (BEVVF) closed up 24.71 percent on Wednesday at $0.3280, and has been trading in a day range of $0.2721...

Best cannabis stock investment could lead to great profits in the near future

In recent months, there has been much debate about which are the best cannabis stocks. There are several states where recreational marijuana is legal,...

Stealth BioTherapeutics Inc. (MITO) stock rose during after-hours, provided no current update.

Stealth BioTherapeutics Inc. (NASDAQ: MITO) stock plunged by 3.57% at last close whereas the MITO stock price gains by 6.17% in the after-hour trading...

CNFinance Holdings Ltd. (CNF) stock fell during after-hours, despite any current update.

CNFinance Holdings Ltd. (NASDAQ: CNF) stock declined by 20.27% in the after-hours trading session. CNFinance Holdings Limited is a significant provider of home equity...

Related news

Looking Under The Hood: What’s Happening To Bee Vectoring Technologies (BEVVF) Stock

Bee Vectoring Technologies International Inc (BEVVF) closed up 24.71 percent on Wednesday at $0.3280, and has been trading in a day range of $0.2721...

Best cannabis stock investment could lead to great profits in the near future

In recent months, there has been much debate about which are the best cannabis stocks. There are several states where recreational marijuana is legal,...

Stealth BioTherapeutics Inc. (MITO) stock rose during after-hours, provided no current update.

Stealth BioTherapeutics Inc. (NASDAQ: MITO) stock plunged by 3.57% at last close whereas the MITO stock price gains by 6.17% in the after-hour trading...

CNFinance Holdings Ltd. (CNF) stock fell during after-hours, despite any current update.

CNFinance Holdings Ltd. (NASDAQ: CNF) stock declined by 20.27% in the after-hours trading session. CNFinance Holdings Limited is a significant provider of home equity...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

1745

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam